Literature DB >> 9187876

Helicobacter pylori stimulates granulocyte-macrophage colony-stimulating factor (GM-CSF) production from cultured antral biopsies and a human gastric epithelial cell line.

I L Beales1, J Calam.   

Abstract

OBJECTIVE: To examine the regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) production by gastric epithelial cells in Helicobacter pylori infection.
DESIGN: The effect of H. pylori infection on gastric GM-CSF production was assessed using short-term culture of antral biopsies. The mechanism of GM-CSF induction was investigated using a gastric epithelial cancer cell line.
METHODS: Production of GM-CSF was assessed by enzyme-linked immunosorbent assay. The mechanism of stimulation of GM-CSF production was examined by co-culture of AGS carcinoma cells with H. pylori and specific stimulants and inhibitors.
RESULTS: Biopsies from H. pylori-negative patients in the basal state did not produce GM-CSF. However, over 24 h in the presence of the active phorbol ester, phorbol myristate acetate (PMA), significant release of GM-CSF was seen. H. pylori-positive biopsies produced significantly more GM-CSF in both the unstimulated and PMA-stimulated state than H. pylori-negative biopsies. Constitutive release of GM-CSF from cultured human gastric AGS cells could be significantly enhanced by co-culture with live H. pylori or the addition of interleukin-1 beta, tumour necrosis factor alpha and PMA, but not by exposure to forskolin. The protein kinase C inhibitor staurosporine abolished the stimulatory effect of PMA on AGS cells, whereas the protein-tyrosine kinase inhibitor herbimycin A prevented the stimulation of GM-CSF production seen with H. pylori and both cytokines.
CONCLUSION: H. pylori enhances GM-CSF production by gastric epithelia. H. pylori appears to stimulate gastric epithelial cells directly to produce GM-CSF and this stimulation involves a tyrosine kinase dependent step. Induction of GM-CSF may play a role in the initiation and perpetuation of gastric inflammation in H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187876     DOI: 10.1097/00042737-199705000-00008

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

Review 1.  Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer.

Authors:  Acacia Lamb; Lin-Feng Chen
Journal:  J Cell Biochem       Date:  2013-03       Impact factor: 4.429

2.  Effect of interlukin-1beta on proliferation of gastric epithelial cells in culture.

Authors:  Ian L P Beales
Journal:  BMC Gastroenterol       Date:  2002-04-05       Impact factor: 3.067

Review 3.  Gastric cancer: genome damaged by bugs.

Authors:  Yanan Zhao; Jinglin Zhang; Alfred S L Cheng; Jun Yu; Ka Fai To; Wei Kang
Journal:  Oncogene       Date:  2020-03-02       Impact factor: 9.867

4.  An Immune Signature for Risk Stratification and Therapeutic Prediction in Helicobacter pylori-Infected Gastric Cancer.

Authors:  Haigang Geng; Zhongyi Dong; Linmeng Zhang; Chen Yang; Tingting Li; Yuxuan Lin; Shouyu Ke; Xiang Xia; Zizhen Zhang; Gang Zhao; Chunchao Zhu
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

5.  GM-CSF is key in the efficacy of vaccine-induced reduction of Helicobacter pylori infection.

Authors:  Laurie Vaillant; Paul Oster; Brynn McMillan; Eulalia Orozco Fernandez; Dominique Velin
Journal:  Helicobacter       Date:  2022-01-29       Impact factor: 5.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.